|
|
|
|
LEADER |
00947nab a2200241 i 4500 |
001 |
publ14516 |
005 |
20190130114737.0 |
008 |
190125s2018 hu o 0|| angol d |
022 |
|
|
|a 0928-0987
|
024 |
7 |
|
|a 10.1016/j.ejps.2018.07.003
|2 doi
|
024 |
7 |
|
|a 3393606
|2 mtmt
|
040 |
|
|
|a SZTE Publicatio Repozitórium
|b hun
|
041 |
|
|
|a angol
|
100 |
1 |
|
|a Pallagi Edina
|
245 |
1 |
0 |
|a Initial Risk Assessment as part of the Quality by Design in peptide drug containing formulation development
|h [elektronikus dokumentum] /
|c Pallagi Edina
|
260 |
|
|
|c 2018
|
300 |
|
|
|a 160-169
|
490 |
0 |
|
|a EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
|v 122
|
700 |
0 |
1 |
|a Ismail Ruba
|e aut
|
700 |
0 |
1 |
|a Paál Tamás
|e aut
|
700 |
0 |
2 |
|a Pannonhalminé Csóka Ildikó
|e aut
|
856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/14516/7/3393606.pdf
|z Dokumentum-elérés
|
856 |
4 |
0 |
|u http://publicatio.bibl.u-szeged.hu/14516/1/8_1-s2.0-S0928098718303014-main3.pdf
|z Dokumentum-elérés
|